PMID- 37445446 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20230718 IS - 2077-0383 (Print) IS - 2077-0383 (Electronic) IS - 2077-0383 (Linking) VI - 12 IP - 13 DP - 2023 Jun 30 TI - Patient-Reported Outcome Measures following Coblation Nucleoplasty for Cervical Discogenic Dizziness. LID - 10.3390/jcm12134413 [doi] LID - 4413 AB - BACKGROUND: There is little research in the literature comparing the efficacy of coblation nucleoplasty with conservative treatment in the treatment of cervical discogenic dizziness and reporting the achieved rate of minimal clinically important differences (MCID) and patient acceptable symptom state (PASS) after surgery. This retrospective study aims to explore the patient-reported outcome measures (PROM) following coblation nucleoplasty for cervical discogenic dizziness and to compare the therapeutic effect of coblation nucleoplasty with prolonged conservative treatment. METHODS: Sixty-one patients with cervical discogenic dizziness and a positive intradiscal diagnostic test eligible for single-level cervical coblation nucleoplasty were included in the study. Among these 61 patients, 40 patients underwent cervical coblation nucleoplasty, while the remaining 21 patients refused surgery and received continued conservative treatment. The primary PROMs were the intensity and frequency of dizziness and secondary PROMs were related to the neck disability index (NDI) and visual analog scale (VAS) for neck pain (VAS-neck) during a 12-month follow-up period. Moreover, the achieved rate of MCID and PASS in both groups was assessed 12 months after surgery. RESULTS: Dizziness intensity, dizziness frequency, VAS-neck score, and NDI score were significantly improved from the baseline at all follow-up time points in both treatment groups, except for showing no significant improvement in dizziness frequency in the conservative treatment group at 6 and 12 months after surgery. However, at each follow-up time point, the above indexes were lower in the surgery group than in the conservative treatment group. In addition, the achieved rates for PASS and MCID in all indexes in the surgery group were significantly higher than those in the conservative treatment group at 12 months after surgery. CONCLUSIONS: Cervical coblation nucleoplasty significantly improved the intensity and frequency of dizziness, neck pain, and NDI in patients with cervical discogenic dizziness, and the results were superior to those from prolonged conservative treatment. Meanwhile, cervical coblation nucleoplasty is a good choice for patients with chronic neck pain and refractory cervical discogenic dizziness who have not demonstrated the indications for open surgery and have not responded well to conservative treatment. FAU - Li, Yongchao AU - Li Y AUID- ORCID: 0000-0002-4460-9702 AD - Department of Orthopedics, The Third Medical Centre of Chinese PLA General Hospital, Beijing 100039, China. FAU - Wu, Bing AU - Wu B AD - Department of Orthopedics, The Third Medical Centre of Chinese PLA General Hospital, Beijing 100039, China. FAU - Li, Mao AU - Li M AD - Department of Surgery, Peking University Hospital, Beijing 100034, China. FAU - Pang, Xiaodong AU - Pang X AD - Department of Orthopedics, The Third Medical Centre of Chinese PLA General Hospital, Beijing 100039, China. FAU - Yang, Liang AU - Yang L AD - Department of Orthopeadics, Featured Medical Center of Chinese People's Armed Police Forces, Tianjin 300162, China. FAU - Dai, Chen AU - Dai C AD - Department of Orthopedics, The Third Medical Centre of Chinese PLA General Hospital, Beijing 100039, China. FAU - Peng, Baogan AU - Peng B AD - Department of Orthopedics, The Third Medical Centre of Chinese PLA General Hospital, Beijing 100039, China. LA - eng PT - Journal Article DEP - 20230630 PL - Switzerland TA - J Clin Med JT - Journal of clinical medicine JID - 101606588 PMC - PMC10342256 OTO - NOTNLM OT - cervical discogenic dizziness OT - cervicogenic dizziness OT - coblation nucleoplasty OT - neck pain OT - patient-reported outcome measures COIS- The authors declare no conflict of interest. EDAT- 2023/07/14 13:06 MHDA- 2023/07/14 13:07 PMCR- 2023/06/30 CRDT- 2023/07/14 01:11 PHST- 2023/05/15 00:00 [received] PHST- 2023/06/25 00:00 [revised] PHST- 2023/06/28 00:00 [accepted] PHST- 2023/07/14 13:07 [medline] PHST- 2023/07/14 13:06 [pubmed] PHST- 2023/07/14 01:11 [entrez] PHST- 2023/06/30 00:00 [pmc-release] AID - jcm12134413 [pii] AID - jcm-12-04413 [pii] AID - 10.3390/jcm12134413 [doi] PST - epublish SO - J Clin Med. 2023 Jun 30;12(13):4413. doi: 10.3390/jcm12134413.